Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

OPINIONS

 hemp-focused-wellness-co-moves-closer-to-profitability-reports-flat-2023-revenue-increase-in-gross-profit

Hemp-focused consumer wellness company CV Sciences, Inc. (OTCQB: CVSI) announced on Thursday its financial results for the year...

 cantor-fitzgerald-maintains-overweight-on-cleanspark-raises-price-target-to-20

Cantor Fitzgerald analyst Josh Siegler maintains Cleanspark (NASDAQ:CLSK) with a Overweight and raises the price target from...

 resources-connection-bolsters-financial-services-expertise-with-strategic-acquisition-of-reference-point

Resources Connection to acquire Reference Point LLC, boosting Financial Consulting Services. CEO Kate Duchene anticipates the t...

 watching-moonlake-immunotherapeutics-shares-spike-higher-traders-circulate-comments-from-betaville

https://www.betaville.co.uk/betaville-intelligence/uncooked-alert-moonlake-immunotherapeutics-said-to/

 ups-unveils-ambitious-growth-strategy-at-2024-investor-day-targets-114-billion-revenue-by-2026-amid-market-reset

United Parcel Service, Inc. (NYSE: UPS) hosted its 2024 Investor and Analyst Day in Louisville, the heart of its global operati...

 rbc-capital-reiterates-outperform-on-verint-systems-maintains-36-price-target

RBC Capital analyst Dan Bergstrom reiterates Verint Systems (NASDAQ:VRNT) with a Outperform and maintains $36 price target.

 da-davidson-maintains-neutral-on-provident-finl-servs-lowers-price-target-to-15

DA Davidson analyst Manuel Navas maintains Provident Finl Servs (NYSE:PFS) with a Neutral and lowers the price target from $...

 b-riley-securities-reiterates-buy-on-pds-biotechnology-lowers-price-target-to-11

B. Riley Securities analyst Kalpit Patel reiterates PDS Biotechnology (NASDAQ:PDSB) with a Buy and lowers the price target f...

 sp-global-ratings-sees-growth-and-innovation-post-ihs-markit-merger-bofa-securities-information-and-business-services-conference-summary

Two years following the landmark merger between S&P Global Inc. and IHS Markit, Martina Cheung, President of S&P Global...

 rbc-capital-reiterates-outperform-on-neumora-therapeutics-maintains-31-price-target

RBC Capital analyst Brian Abrahams reiterates Neumora Therapeutics (NASDAQ:NMRA) with a Outperform and maintains $31 price t...

 b-riley-securities-reiterates-buy-on-cognition-therapeutics-maintains-5-price-target

B. Riley Securities analyst Mayank Mamtani reiterates Cognition Therapeutics (NASDAQ:CGTX) with a Buy and maintains $5 price...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist